AR transcriptional activity was assayed as previously described [55]. Briefly, LNCaP human prostate cancer cells (LN-ARR2PB-eGFP), stably transfected with eGFP reporter driven by an androgen responsive probasin-derived promoter (ARR2PB), were grown in phenol red free RPMI 1640 media supplemented with 5% charcoal stripped serum (CSS). After 5 days, the cells were plated into a 96-well plate (35,000 cells/well) with 0.1 nM of the synthetic androgen R1881 and increasing concentrations (0−100 μM) of test compounds. Fluorescence (excitation 485 nm, emission 535 nm) was measured after 3 days of incubation with the compounds.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.